Medley, Inc. (TYO:4480)
Japan · Delayed Price · Currency is JPY 3,200.00
+15.00 (0.47%)
Aug 8, 2025, 3:30 PM JST
Medley Revenue
Medley had revenue of 8.14B JPY in the quarter ending March 31, 2025, with 36.90% growth. This brings the company's revenue in the last twelve months to 31.50B, up 42.90% year-over-year. In the year 2024, Medley had annual revenue of 29.30B with 42.71% growth.
Revenue (ttm)
31.50B
Revenue Growth
+42.90%
P/S Ratio
3.24
Revenue / Employee
21.18M
Employees
1,487
Market Cap
102.15B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 29.30B | 8.77B | 42.71% |
| Dec 31, 2023 | 20.53B | 6.35B | 44.74% |
| Dec 31, 2022 | 14.19B | 3.32B | 30.58% |
| Dec 31, 2021 | 10.86B | 4.03B | 59.05% |
| Dec 31, 2020 | 6.83B | 2.07B | 43.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,196.22B |
| Daiichi Sankyo Company | 1,924.68B |
| Takeda Pharmaceutical Company | 4,480.25B |
| HOYA Corporation | 876.09B |
| Otsuka Holdings | 2,401.70B |
| Terumo | 1,036.17B |
| Astellas Pharma | 1,944.99B |
| Shionogi & | 440.50B |